FI893002A - Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI893002A
FI893002A FI893002A FI893002A FI893002A FI 893002 A FI893002 A FI 893002A FI 893002 A FI893002 A FI 893002A FI 893002 A FI893002 A FI 893002A FI 893002 A FI893002 A FI 893002A
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
peptide derivatives
useful peptide
derivatives
Prior art date
Application number
FI893002A
Other languages
English (en)
Swedish (sv)
Other versions
FI893002A0 (fi
FI94351C (fi
FI94351B (fi
Inventor
Stephen Henderson Buck
John Leonard Krstenansky
Iii Chester Fred Hassmann
James Ray Mccarthy
Scott Lee Harbeson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI893002A0 publication Critical patent/FI893002A0/fi
Publication of FI893002A publication Critical patent/FI893002A/fi
Application granted granted Critical
Publication of FI94351B publication Critical patent/FI94351B/fi
Publication of FI94351C publication Critical patent/FI94351C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI893002A 1988-06-20 1989-06-19 Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi FI94351C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20892688A 1988-06-20 1988-06-20
US20892688 1988-06-20

Publications (4)

Publication Number Publication Date
FI893002A0 FI893002A0 (fi) 1989-06-19
FI893002A true FI893002A (fi) 1989-12-21
FI94351B FI94351B (fi) 1995-05-15
FI94351C FI94351C (fi) 1995-08-25

Family

ID=22776618

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893002A FI94351C (fi) 1988-06-20 1989-06-19 Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi

Country Status (19)

Country Link
EP (1) EP0347802B1 (fi)
JP (1) JP2711720B2 (fi)
KR (1) KR0136605B1 (fi)
CN (1) CN1030703C (fi)
AR (1) AR246085A1 (fi)
AT (1) ATE107312T1 (fi)
AU (1) AU619857B2 (fi)
CA (1) CA1340824C (fi)
DE (1) DE68916113T2 (fi)
DK (1) DK174964B1 (fi)
ES (1) ES2057024T3 (fi)
FI (1) FI94351C (fi)
HU (1) HU204850B (fi)
IE (1) IE61362B1 (fi)
IL (1) IL90637A (fi)
NO (1) NO176105C (fi)
NZ (1) NZ229552A (fi)
PT (1) PT90902B (fi)
ZA (1) ZA894533B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
ZA906188B (en) * 1989-08-10 1991-06-26 Merrell Dow Pharma Cyclic neurokinin a antagonists
IE77033B1 (en) * 1989-08-16 1997-11-19 Univ Tulane Substance P antagonists
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69230287T2 (de) * 1991-04-22 2000-05-11 Mallinckrodt Medical, Inc. Verbindungen und pharmazeutische zusammensetzungen zum nachweis und zur lokalisierung von geweben mit neurokinin-1-rezeptoren
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5625060A (en) * 1991-05-03 1997-04-29 Elf Sanofi Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present
CA2109322C (en) * 1991-05-23 2002-11-05 Judson V. Edwards Bombesin analogs
GB9727123D0 (en) * 1997-12-22 1998-02-25 Int Centre Genetic Eng & Bio Synthesis of diamines
JP2000021345A (ja) 1998-07-06 2000-01-21 Hitachi Ltd 走査型電子顕微鏡

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302926C (en) * 1986-03-04 1992-06-09 Hideo Sugawara Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent
IT1233696B (it) * 1989-05-29 1992-04-14 Menarini Farma Ind Peptidi di sintesi antagonisti della neurochinina a. loro sali e relativi procedimenti di fabbricazione
ZA906188B (en) * 1989-08-10 1991-06-26 Merrell Dow Pharma Cyclic neurokinin a antagonists

Also Published As

Publication number Publication date
IL90637A (en) 1993-07-08
AU3652389A (en) 1989-12-21
EP0347802A3 (en) 1991-07-17
HUT50196A (en) 1989-12-28
FI893002A0 (fi) 1989-06-19
IE61362B1 (en) 1994-11-02
CN1030703C (zh) 1996-01-17
NZ229552A (en) 1992-06-25
CN1039597A (zh) 1990-02-14
DK174964B1 (da) 2004-04-05
DE68916113D1 (de) 1994-07-21
EP0347802B1 (en) 1994-06-15
IE891987L (en) 1989-12-20
AR246085A1 (es) 1994-03-30
PT90902A (pt) 1989-12-29
KR0136605B1 (ko) 1998-04-25
DK301889A (da) 1989-12-21
JP2711720B2 (ja) 1998-02-10
CA1340824C (en) 1999-11-16
DK301889D0 (da) 1989-06-19
EP0347802A2 (en) 1989-12-27
PT90902B (pt) 1994-12-30
ATE107312T1 (de) 1994-07-15
HU204850B (en) 1992-02-28
ZA894533B (en) 1990-03-28
AU619857B2 (en) 1992-02-06
NO176105B (no) 1994-10-24
JPH0245497A (ja) 1990-02-15
NO176105C (no) 1995-02-01
IL90637A0 (en) 1990-01-18
FI94351C (fi) 1995-08-25
FI94351B (fi) 1995-05-15
KR910000791A (ko) 1991-01-30
NO892542L (no) 1989-12-21
DE68916113T2 (de) 1994-09-22
NO892542D0 (no) 1989-06-19
ES2057024T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI903737A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pentafluorietyyli-substituoitujen valiini- tai fenyylialaniinijohdannaisten valmistamiseksi
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI860484A (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI890283A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI884910A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI94351B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI893115A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten mitomysiinifosfaattijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.